Diane supports the design and delivery of commercialization programs that help ARPA-H performers bring breakthrough health innovations to market. She brings over a decade of experience revitalizing multi-million-dollar federal initiatives, building cross-institution collaborations, and guiding innovators through adoption and regulatory pathways. Diane has advanced equity in biopharma leadership pipelines, authored reproducibility standards adopted internationally, and advised on commercialization strategy across therapeutics, diagnostics, and devices. She holds a Ph.D. in Biomedical Engineering and certifications in data science and artificial intelligence / machine learning.